NEW YORK, April 29 (GenomeWeb News) - Shimadzu and the Institute of Medical Science at the University of Tokyo plan to jointly conduct genomic and proteomic analyses with the goal of identifying new disease-related genes and biomarkers.
Further information was not immediately provided.